{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:58:34Z","timestamp":1789084714181,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council Canada","doi-asserted-by":"publisher","award":["MR\/R014019\/1"],"award-info":[{"award-number":["MR\/R014019\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"ANID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1200227"],"award-info":[{"award-number":["1200227"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cgh.2023.02.017","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T11:40:14Z","timestamp":1677498014000},"page":"2124-2134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan P.","family":"Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Addolorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Thursz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.02.017_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2018.11.005","article-title":"Endpoints and patient stratification in clinical trials for alcoholic hepatitis","volume":"70","author":"Mathurin","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2023.02.017_bib4","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","article-title":"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis","volume":"10","author":"Argemi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cgh.2023.02.017_bib5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2023.02.017_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2016.06.018","article-title":"Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide","volume":"65","author":"Stein","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib8","series-title":"Global status report on alcohol and health 2018","author":"Organization","year":"2019"},{"key":"10.1016\/j.cgh.2023.02.017_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/alcalc\/agac013","article-title":"Alcohol consumption: medical implications, the liver and beyond","volume":"57","author":"Meza","year":"2022","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cgh.2023.02.017_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gutjnl-2019-320446","article-title":"Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients","volume":"70","author":"Hagstrom","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.02.017_bib11","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/hep.32016","article-title":"Impact of public health policies on alcohol-associated liver disease in Latin America: an ecological multinational study","volume":"74","author":"Diaz","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib12","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2022.4308","article-title":"Alcohol-related deaths during the COVID-19 pandemic","volume":"327","author":"White","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.02.017_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/apt.16461","article-title":"Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics","volume":"54","author":"Singal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.02.017_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2017.11.019","article-title":"Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life","volume":"68","author":"Hagstrom","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/jhep.2002.31782","article-title":"Risk factors of fibrosis in alcohol-induced liver disease","volume":"35","author":"Raynard","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib17","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2023.02.017_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas","volume":"7","author":"Diaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research","volume":"32","author":"Kleiner","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2023.02.017_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.02.017_bib25","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.02.017_bib26","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.02.017_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib33","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/hep.31984","article-title":"Clinical course and risk factors for infection in severe forms of alcohol-associated liver disease","volume":"74","author":"Otero Sanchez","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib34","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/lt.25328","article-title":"A\u00a0validated score predicts acute kidney injury and survival in patients with alcoholic hepatitis","volume":"24","author":"Sujan","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.02.017_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.02.017_bib36","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo: a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib39","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2023.02.017_bib40","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.02.017_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cgh.2023.02.017_bib43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.07.006","article-title":"Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF","author":"Engelmann","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open label, dose escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcoholic hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100063","article-title":"25-Hydroxycholesterol 3-sulfate is an endogenous ligand of DNA methyltransferases in hepatocytes","volume":"62","author":"Wang","year":"2021","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cgh.2023.02.017_bib47","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.2021.16070","article-title":"A\u00a0review of the diagnosis and treatment of alcohol-associated liver disease: reply","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.02.017_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.gastro.2015.06.020","article-title":"MELDing the Lille score to more accurately predict mortality in alcoholic hepatitis","volume":"194","author":"Kamath","year":"2015","journal-title":"Gastroenterogy"},{"key":"10.1016\/j.cgh.2023.02.017_bib49","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis","volume":"265","author":"Lee","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2023.02.017_bib51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2468-1253(21)00430-1","article-title":"Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study","volume":"7","author":"Louvet","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2468-1253(19)30451-0","article-title":"Liver transplantation in patients with alcohol-related liver disease: current status and future directions","volume":"5","author":"Mathurin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/lt.25448","article-title":"Underestimation of liver transplantation for alcoholic hepatitis in the National Transplant Database","volume":"25","author":"Lee","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.02.017_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2023.02.017_bib55","first-page":"E253","article-title":"Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study","volume":"37","author":"Johnson","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2023.02.017_bib56","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2023.02.017_bib57","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.02.017_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","article-title":"Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation","volume":"19","author":"Arab","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cgh.2023.02.017_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.cgh.2023.02.017_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2023.02.017_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.alcohol.2006.05.003","article-title":"Study of hepatotoxicity of naltrexone in the treatment of alcoholism","volume":"38","author":"Yen","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.cgh.2023.02.017_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.cgh.2023.02.017_bib64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/a-1798-2872","article-title":"Treating alcohol use disorder in patients with alcohol-associated liver disease: controversies in pharmacological therapy","volume":"42","author":"Tarli","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2023.02.017_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/14656566.2014.863278","article-title":"Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention","volume":"15","author":"Skala","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2023.02.017_bib66","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2023.02.017_bib67","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2215-0366(18)30303-1","article-title":"Baclofen for the treatment of alcohol use disorder: the Cagliari Statement","volume":"5","author":"Agabio","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cgh.2023.02.017_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.02.017_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dld.2019.12.008","article-title":"Alcohol associated liver disease 2020: a clinical practice guideline by the Italian Association for the Study of the Liver (AISF)","volume":"52","author":"Addolorato","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2023.02.017_bib70","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2019.04.012","article-title":"Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis","volume":"157","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib71","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.02.017_bib72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/milmed\/168.5.364","article-title":"Use of biomarkers of heavy drinking in health care practice","volume":"168","author":"Allen","year":"2003","journal-title":"Mil Med"},{"key":"10.1016\/j.cgh.2023.02.017_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1432-2277.2004.tb00395.x","article-title":"Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis","volume":"17","author":"Berlakovich","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2023.02.017_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11419-021-00588-5","article-title":"Ethyl glucuronide and ethyl sulfate: a review of their roles in forensic toxicology analysis of alcohol postmortem","volume":"40","author":"Alsayed","year":"2022","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.cgh.2023.02.017_bib75","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"Viel","year":"2012","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:43:16Z","timestamp":1761543796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1542356523001593"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.02.017","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}